Monopar Therapeutics (MNPR) Other Operating Expenses (2017)
Monopar Therapeutics' Other Operating Expenses history spans 1 years, with the latest figure at $14.5 million for Q3 2017.
- For Q3 2017, Other Operating Expenses changed N/A year-over-year to $14.5 million; the TTM value through Jun 2018 reached $14.5 million, changed N/A, while the annual FY2024 figure was $9.0 million, N/A changed from the prior year.
- Other Operating Expenses for Q3 2017 was $14.5 million at Monopar Therapeutics.
- Across five years, Other Operating Expenses topped out at $14.5 million in Q3 2017 and bottomed at $14.5 million in Q3 2017.